IRADIMED CORP

IRADIMED CORPORATION develops, manufactures, and sells medical devices, disposables, and services engineered for magnetic resonance imaging environments. Its core offerings include the MRidium 3870 and MRidium 3860+ non-magnetic intravenous infusion pump systems, proprietary single-use intravenous tubing sets, and the IRadimed 3880 patient vital signs monitoring system. The company also supplies ferromagnetic detection devices, replacement accessories, and maintenance contracts. Its products serve hospitals and acute care facilities worldwide, particularly radiology departments, intensive care units, emergency rooms, and surgical centers requiring continuous medication delivery and patient monitoring during scans.

The company distributes products in the United States and roughly 80 foreign countries. Within the United States, commercial operations rely on a direct sales force consisting of 29 field representatives, four regional sales directors, and ten clinical application specialists. Outside the domestic market, it markets products through third-party distributors. Cumulatively, the business has distributed roughly 13,098 infusion pump channels and 3,397 vital signs monitoring systems. The provided report does not state the location of the corporate headquarters.

Summary of the business section of Iradimed's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we had 166 full-time employees, including 55 in manufacturing and service, 68 in sales, marketing and customer support services, 14 in regulatory affairs and quality assurance, 14 in finance and administration and 15 in research and development.”